Impact Factor
4.15
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.23
1,284 total citations
h5-index
45
h5 depth signal
Cited share
86.2%
187 of 217
Total citations
1,284
Citation footprint
Metric signal
7.00
External metric anchor
Self-citation
2.7%
35 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
568
China
257
South Korea
212
United States
130
Italy
66
Citing Fields of Research
Digestive Disorders
707
Oncology
677
Liver & Colon Cancer
176
Abdominal Surgery
167
Immunology
135
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,369
Articles tracked across the journal lifetime
Indexed publication set
217
187 cited publications
Last 12 months
132
11.0 publications/month
Open access share
37.9%
50 OA publications in the last year
Leading citing country
Japan
568 citing publications
Leading citing field
Digestive Disorders
707 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v4n1, 2001-
v4n1, 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Oncology
Immunology
Abdominal Surgery
Issuing & Sponsoring Bodies
Contributor
International Gastric Cancer Association
Contributor
Nihon Igan Gakkai
Broad Categories
Gastroenterology
Neoplasms
Digestive Disorders
MeSH Descriptors
Stomach Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10120-026-01800-4
Open DOI
Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026
Background: Gastric cancer (GC) remains a major global health burden, and early detection is essential for improving patient outcomes. Although GC screening has been widely implemented in East Asian countries with a high disease burden, ...
02
03
04
DOI 10.1007/s10120-026-01805-z
Open DOI
Longitudinal assessment of quality-of-life after gastrectomy for gastric cancer: a prospective study
Background: The longitudinal recovery process for postoperative quality of life (QOL) after gastrectomy remains incompletely understood. We prospectively evaluated temporal changes in QOL using the Postgastrectomy Syndrome Assessment Sca...
05
DOI 10.1007/s10120-026-01787-y
Open DOI
Comparison of geriatric assessment with provider’s clinical assessment among older adults with gastroesophageal cancer
06
07
DOI 10.1007/s10120-026-01799-8
Open DOI
A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
Background: There is currently no established chemotherapy regimen for early recurrence of pathological stage III gastric cancer (GC) following adjuvant chemotherapy with docetaxel plus S-1 (DS) after D2 gastrectomy. We aimed to evaluate...
08
09
10
DOI 10.1007/s10120-026-01798-9
Open DOI
External validation and comparison of five prediction models for lymph node metastasis after noncurative endoscopic submucosal dissection for early gastric cancer
Background: Additional gastrectomy is recommended after noncurative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) despite the low incidence of lymph node metastasis (LNM). The eCura system, W-eCura score, and 11-p...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v. 1, no. 1 (1998)20011126 Notice published Printed on acid-free paper